NFE2L2 and neoplasm: Because most of the included non-neoplastic brain tissues in this study revealed reactive astrocytosis, our results imply that immunohistochemical analysis of Nrf2 overexpression could not only help to discriminate glioma from gliosis in brain lesions, but also to discern the location of safe tumor margins in cases of PBT.